Andreas Krause

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Journal of pharmacokinetics and pharmacodynamics

CPT: pharmacometrics & systems pharmacology

Pharmaceutical statistics

British journal of clinical pharmacology

Idorsia Pharmaceuticals Ltd

Universität Basel (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Idorsia Pharmaceuticals Ltd Jun 15 2017

Switzerland

Senior Director Data Management, Modeling and Simulation :: Clinical Pharmacology

Pharsight Corporation

United States

Senior modeling and simulation scientist

Novartis Pharma AG

Switzerland

Senior scientist :: Modeling and Simulation/Biostatistics

Education History

Universität Basel

Switzerland

PHD :: Economics

Technische Universität Dortmund Fakultät Statistik

Germany

MSC :: Statistics

Publications

Janneke M Brussee, Patricia N Sidharta, Jasper Dingemanse, Andreas Krause
Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with or without essential or resistant hypertension. Journal of pharmacokinetics and pharmacodynamics 51 (3) (2024)
Janneke M Brussee, Patricia N Sidharta, Jasper Dingemanse, Andreas Krause
Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with or without essential or resistant hypertension. Journal of pharmacokinetics and pharmacodynamics 51 (3) (2024)
Janneke M Brussee, Patricia N Sidharta, Jasper Dingemanse, Andreas Krause
Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with or without essential or resistant hypertension. Journal of pharmacokinetics and pharmacodynamics (2024)
Chih-Hsuan Hsin, Jasper Dingemanse, Andrea Henrich, Corine Bernaud, Martine Gehin, Andreas Krause
Mind the Gap: Model-Based Switching from Selatogrel to Maintenance Therapy with Oral P2Y12 Receptor Antagonists. Biomolecules 13 (9) (2023)
Marion Anliker-Ort, Chih-Hsuan Hsin, Andreas Krause, Marc Pfister, John van den Anker, Jasper Dingemanse, Priska Kaufmann
Modeling time-delayed concentration-QT effects with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5a 1 receptor) antagonist. Pharmacology research & perspectives 11 (4) (2023)
Andreas Krause, Dominik Lott, Janneke M Brussee, Clemens Muehlan, Jasper Dingemanse
Population pharmacokinetic modeling of daridorexant, a novel dual orexin receptor antagonist. CPT: pharmacometrics & systems pharmacology (2022)
Andrea Henrich, Pierre-Eric Juif, Jasper Dingemanse, Andreas Krause
PK/PD modeling of a clazosentan thorough QT study with hysteresis in concentration-QT and RR-QT. Journal of pharmacokinetics and pharmacodynamics 48 (2) (2021)
Dominik Lott, Pierre-Eric Juif, Jasper Dingemanse, Andreas Krause
Modelling pharmacokinetics and pharmacodynamics of the selective S1P1 receptor modulator cenerimod in healthy subjects and systemic lupus erythematosus patients. British journal of clinical pharmacology 86 (4) (2020)
Andreas Krause, Charlotte Kloft, Wilhelm Huisinga, Mats O Karlson, José Pinheiro, Robert R Bies, James Rogers, France Mentré, Bret J Musser, null null
Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593-606, Sep/Oct 2018, DOI: 10.1002/pst.1873. Pharmaceutical statistics 18 (3) (2019)

Andreas Krause.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andreas Krause